Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2010 - 2026)

Pacific Biosciences Of California has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $48.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 57.47% year-over-year to $48.2 million; the trailing twelve-month figure through Mar 2026 stood at -$65.2 million (down 388.3% YoY), and the FY2024 full-year result was $34.9 million, down 95.47% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $48.2 million, up from -$280.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $355.4 million in Q3 2022, with the low at -$355.4 million in Q4 2022.
• Average Change in Acquisitions & Divestments over 5 years is $50.2 million, with a median of $84.6 million recorded in 2025.
• Year-over-year, Change in Acquisitions & Divestments soared 27068.07% in 2024 and slumped 1145.3% in 2025.
• Tracing PACB's Change in Acquisitions & Divestments over 5 years: stood at -$355.4 million in 2022, then jumped by 138.9% to $138.3 million in 2023, then sank by 80.62% to $26.8 million in 2024, then tumbled by 1145.3% to -$280.1 million in 2025, then soared by 117.23% to $48.2 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $48.2 million (Q1 2026), -$280.1 million (Q4 2025), and $84.6 million (Q3 2025), per Business Quant data.

Peer Comparison